Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Criteria for Causality: Bradford Hill Criteria - II01:28

Criteria for Causality: Bradford Hill Criteria - II

The Bradford Hill criteria serve as guidelines for establishing causative links in epidemiological research. Beyond Strength, Consistency, Specificity, and Temporality, key criteria also include Biological Gradient, Plausibility, Coherence, Experiment, and Analogy. These principles assist scientists in assessing the likelihood of causation in complex biological contexts. Below is a summary of these concepts:
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Basic ethical aspects of living organ donation].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2003
Same author

[Hemophagocytic syndrome (case report and literature review)].

Vnitrni lekarstvi·2003
Same author

Anatomical study of the blood supply of the coxal bone: radiological and clinical application.

Surgical and radiologic anatomy : SRA·2002
Same author

Reduced nephrotoxicity of conventional amphotericin B therapy after minimal nephroprotective measures: animal experiments and clinical study.

The Journal of infectious diseases·2002
Same author

Structure of nanocrystalline anatase solved and refined from electron powder data.

Acta crystallographica. Section A, Foundations of crystallography·2002
Same author

Interleukin-2 activation of haematopoietic stem cells.

Acta medica Austriaca·2002

Related Experiment Video

Updated: Jul 10, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

Structure-activity relationship analysis tools: validation and applicability in predicting carcinogens.

J Mayer1, M A Cheeseman, M L Twaroski

  • 1Food and Drug Administration, Division of Food Contact Notifications, HFS-275, 5100 Paint Branch Parkway, College Park, MD 20740, USA. julie.mayer@fda.hhs.gov

Regulatory Toxicology and Pharmacology : RTP
|November 21, 2007
PubMed
Summary
This summary is machine-generated.

Structure-activity relationship (SAR) software and structural alerts can predict chemical carcinogenicity, especially for low-exposure compounds. These methods complement genetic toxicity tests in a weight-of-evidence approach for risk assessment.

More Related Videos

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
09:33

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Published on: March 20, 2018

Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
09:57

Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria

Published on: December 14, 2016

Related Experiment Videos

Last Updated: Jul 10, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
09:33

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Published on: March 20, 2018

Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
09:57

Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria

Published on: December 14, 2016

Area of Science:

  • Toxicology
  • Computational Chemistry
  • Risk Assessment

Background:

  • Carcinogenicity prediction is crucial for public health and regulatory decisions.
  • Structure-activity relationship (SAR) software and genetic toxicity tests are common methods for assessing chemical carcinogenicity.
  • Existing methods require validation and comparison for optimal use in risk assessment.

Purpose of the Study:

  • To validate and compare the predictivity of OncoLogic, MultiCASE (MCASE), Ashby-Tennant structural alerts, and genetic toxicity testing for carcinogenicity.
  • To evaluate the sensitivity and specificity of these methods, individually and in combination.
  • To assess the performance of these methods for potent carcinogens.

Main Methods:

  • Utilized 650 compounds from the Carcinogenic Potency Database (CPDB) with known carcinogenicity results.
  • Compared the predictive accuracy of OncoLogic (v4.1), MCASE (v3.1), Ashby-Tennant alerts, and genetic toxicity data.
  • Examined sensitivity for carcinogen prediction and specificity for non-carcinogen prediction.

Main Results:

  • SAR analysis programs and structural alerts demonstrated good performance, particularly for compounds with low human exposure.
  • These computational methods showed potential to supplement traditional genetic toxicity testing.
  • Each method exhibited limitations in its applicability and predictive scope.

Conclusions:

  • SAR analysis tools and structural alerts are valuable for predicting carcinogenicity, especially in a weight-of-evidence framework.
  • These computational approaches can enhance the assessment of chemical carcinogenicity alongside genetic toxicity data.
  • Careful consideration of method-specific limitations is necessary for accurate carcinogenicity prediction.